TF and lung carcinoma: The results indicated enhanced tumor growth inhibition and selective cytotoxicity towards lung carcinoma cells, demonstrating the potential of transferrin-conjugated carriers in improving the delivery and efficacy of chemotherapeutic agents in lung cancer treatment [30].